Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A study of the Leukemia Cooperative Group of the EORTC and GIMEMA

By Keating S.   de Witte T.   Suciu S.   Mandelli F.   Damasio E.   Willemze R.   Morra E.   Amadori S.   Dardenne M.   Vegna M.L.   Zittoun R.A.  

European Journal of Cancer, Vol. 35, Iss. 10, 1999-10 ,pp. : 1440-1447

Elsevier

Access to resources Recommend Favorite

Proteasome Inhibition in Myelodysplastic Syndromes and Acute Myelogenous Leukemia Cell Lines

By Liesveld Jane L.   Rosell Karen E.   Bechelli Jeremy   Lu Chaohui   Messina Patti   Mulford Deborah   Ifthikharuddin J. J.   Jordan Craig T.   Phillips II Gordon L.  

Cancer Investigation, Vol. 29, Iss. 7, 2011-07 ,pp. : 439-450

Informa Healthcare

Access to resources Recommend Favorite

Transformation of Myelodysplastic Syndrome to Acute Lymphoblastic Leukemia in a Child

By Gupta Vineeta  

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 3, 2010-09 ,pp. : 111-113

Springer Publishing Company

Access to resources Recommend Favorite

Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors

By Kaplan Henry   Malmgren Judith   Li Christopher   Calip Gregory  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 629-636

Springer Publishing Company

Access to resources Recommend Favorite

Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

By Prebet Thomas   Charbonnier Aude   Gelsi-Boyer Véronique   Mozziconacci Marie Joelle   Blaise Didier   Vey Norbert  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1538-1540

Informa Healthcare

Access to resources Recommend Favorite